4//SEC Filing
Lunger John 4
Accession 0001104659-23-004376
CIK 0001621227other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 9:06 PM ET
Size
11.3 KB
Accession
0001104659-23-004376
Insider Transaction Report
Form 4
Lunger John
Chief Patient Supply Officer
Transactions
- Award
Option to purchase Ordinary Shares
2023-01-17+190,920→ 190,920 totalExercise: $0.00From: 2024-01-17Exp: 2025-03-15→ Ordinary Shares (190,920 underlying) - Award
Option to purchase Ordinary Shares
2023-01-17+1,407,072→ 1,407,072 totalExercise: $0.31Exp: 2033-01-17→ Ordinary Shares (1,407,072 underlying) - Award
Option to purchase Ordinary Shares
2023-01-17+314,256→ 314,256 totalExercise: $0.00→ Ordinary Shares (314,256 underlying)
Footnotes (6)
- [F1]The exercise price was converted from GBP0.26 based on an exchange rate of U.S.$ 1.219333 to GBP1.00. The actual exercise price will be the pounds sterling amount.
- [F2]Exercisable as to 351,768 Ordinary Shares on January 17, 2024 and will be exercisable as to the remainder in monthly installments of 29,310 Ordinary Shares on the seventeenth of each month from February 17, 2024 through December 17, 2026 and 29,454 Ordinary Shares on January 17, 2027.
- [F3]The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of U.S.$ 1.219333 to GBP1.00. The actual exercise price will be the pounds sterling amount.
- [F4]Exercisable as to 78,564 Ordinary Shares on January 17, 2024 and will be exercisable as to the remainder in annual installments of 78,564 Ordinary Shares on the seventeenth of each January from January 17, 2025 through January 17, 2027.
- [F5]The expiration date of each annual installment of ordinary shares is March 15 of the calendar year following the year in which that installment becomes exercisable.
- [F6]The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of $U.S. 1.219333 to GBP1.00. The actual exercise price will be the pounds sterling amount.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeother
Related Parties
1- filerCIK 0001784487
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 9:06 PM ET
- Size
- 11.3 KB